Page last updated: 2024-08-26

mci 9038 and Anti-Phospholipid Antibody Syndrome

mci 9038 has been researched along with Anti-Phospholipid Antibody Syndrome in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (9.09)	18.2507
2000's	5 (45.45)	29.6817
2010's	4 (36.36)	24.3611
2020's	1 (9.09)	2.80

Authors

Authors	Studies
Clerici, M; Peyvandi, F; Scalambrino, E; Tripodi, A	1
Ahadizadeh, EN; Buethe, DJ; Honda, K; Manzoor, NF; Merati, M; Mowry, SE; Semaan, M	1
Smythe, MA; Warkentin, TE; Woodhouse, AL; Zakalik, D	1
Fimmers, R; Harbrecht, U; Mayer, G; Müller, J; Oldenburg, J; Pötzsch, B; Rühl, H	1
Ahmed, S; Karim, A; Mattana, J; Patel, D; Siddiqui, R	1
Pendleton, R; Rodgers, GM; Wheeler, MM	1
Haines, ST; Hursting, MJ; LaMonte, MP; Mikdashi, JA; Patterson, SL	1
Athar, U; Gajra, A; Hudson, J; Husain, J; Lynch, J	1
Akiguchi, I; Kimura, J; Kinoshita, M; Nishimura, M; Osaki, A; Tomimoto, H; Wakita, H	1
Kato, T; Morita, A	1

Reviews

1 review(s) available for mci 9038 and Anti-Phospholipid Antibody Syndrome

Article	Year
Anticoagulation strategies for treatment of ischemic stroke and antiphospholipid syndrome: case report and review of the literature. Pharmacotherapy, 2006, Volume: 26, Issue:10 Topics: Anticoagulants; Antiphospholipid Syndrome; Arginine; Azathioprine; Brain Ischemia; Dexamethasone; Humans; Male; Middle Aged; Pipecolic Acids; Stroke; Sulfonamides; Warfarin	2006

Other Studies

10 other study(ies) available for mci 9038 and Anti-Phospholipid Antibody Syndrome

Article	Year
Impact of a commercially available DOAC absorbent on two integrated procedures for lupus anticoagulant detection in plasma containing argatroban. International journal of laboratory hematology, 2022, Volume: 44, Issue:5 Topics: Anticoagulants; Antiphospholipid Syndrome; Arginine; Humans; Lupus Coagulation Inhibitor; Pipecolic Acids; Sulfonamides	2022
Situational Awareness and Patient Safety. AORN journal, 2017, Volume: 106, Issue:5 Topics: Adult; Antiphospholipid Syndrome; Antithrombins; Arginine; Awareness; Female; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Male; Medication Errors; Middle Aged; Occult Blood; Patient Safety; Pipecolic Acids; Sulfonamides	2017
Reversible Auricular Necrosis Secondary to Systemic Thrombosis. JAMA otolaryngology-- head & neck surgery, 2018, 09-01, Volume: 144, Issue:9 Topics: Anticoagulants; Antiphospholipid Syndrome; Arginine; Ear Auricle; Ear Diseases; Female; Heparin; Humans; Necrosis; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Thrombosis	2018
Venous limb gangrene and fatal hemorrhage: adverse consequences of HIT "overdiagnosis" in a patient with antiphospholipid syndrome. American journal of hematology, 2011, Volume: 86, Issue:2 Topics: Anticoagulants; Antiphospholipid Syndrome; Arginine; Diagnostic Errors; Drug Monitoring; Fatal Outcome; Female; Gangrene; Hemorrhage; Humans; Lung Diseases; Middle Aged; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Upper Extremity; Vascular Diseases; Warfarin	2011
Thrombin inhibition profiles in healthy individuals and thrombophilic patients. Thrombosis and haemostasis, 2012, Volume: 107, Issue:5 Topics: Adult; Aged; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Antithrombin Proteins; Antithrombins; Arginine; Blood Coagulation; Blood Coagulation Tests; Case-Control Studies; Female; Germany; Half-Life; Humans; Kinetics; Male; Middle Aged; Phenotype; Pipecolic Acids; Sulfonamides; Thrombin; Thrombophilia; Young Adult	2012
Low-molecular weight heparin: treatment failure in a patient with primary antiphospholipid antibody syndrome. The American journal of the medical sciences, 2002, Volume: 324, Issue:5 Topics: Adolescent; Anticoagulants; Antiphospholipid Syndrome; Arginine; Arm; Enoxaparin; Female; Folic Acid; Heparin, Low-Molecular-Weight; Humans; International Normalized Ratio; Pipecolic Acids; Pulmonary Embolism; Sulfonamides; Treatment Failure; Treatment Outcome; Venous Thrombosis; Warfarin	2002
Argatroban dosing of patients with heparin-induced thrombocytopenia and an elevated aPTT due to antiphospholipid antibody syndrome. The Annals of pharmacotherapy, 2006, Volume: 40, Issue:5 Topics: Adult; Anticoagulants; Antiphospholipid Syndrome; Arginine; Female; Fondaparinux; Heparin; Humans; Middle Aged; Partial Thromboplastin Time; Pipecolic Acids; Polysaccharides; Sulfonamides; Thrombocytopenia; Thrombosis	2006
Prolonged half-life of argatroban in patients with renal dysfunction and antiphospholipid antibody syndrome being treated for heparin-induced thrombocytopenia. American journal of hematology, 2008, Volume: 83, Issue:3 Topics: Anticoagulants; Antiphospholipid Syndrome; Arginine; Cholangiopancreatography, Endoscopic Retrograde; Female; Half-Life; Heparin; Humans; Kidney Failure, Chronic; Lupus Erythematosus, Systemic; Middle Aged; Peritoneal Dialysis; Pipecolic Acids; Sulfonamides; Thrombocytopenia; Treatment Outcome; Warfarin	2008
Effects of antithrombin on Binswanger's disease with antiphospholipid antibody syndrome. Neurology, 1999, Jan-15, Volume: 52, Issue:2 Topics: Antiphospholipid Syndrome; Antithrombin III; Antithrombins; Arginine; Basal Ganglia Diseases; Dementia, Multi-Infarct; Female; Fibrinogen; Hemostasis; Humans; Magnetic Resonance Imaging; Middle Aged; Peptide Hydrolases; Pipecolic Acids; Sulfonamides	1999
[Improvement of cerebral perfusion with argatroban in a patient with antiphospholipid syndrome]. Ryumachi. [Rheumatism], 2000, Volume: 40, Issue:5 Topics: Adult; Antiphospholipid Syndrome; Antithrombins; Arginine; Cerebrovascular Circulation; Female; Humans; Iodine Radioisotopes; Iofetamine; Pipecolic Acids; Radionuclide Imaging; Radiopharmaceuticals; Sulfonamides	2000